Number of the records: 1
skúšanie klinické, fáza I, ako téma
Record number d017321 Date 06.06.2025 Type M - MESH Topical term skúšanie klinické, fáza I, ako téma Other term English (Pseudonym) Clinical Trials, Phase I
English (Pseudonym) Drug Evaluation, FDA Phase I
English (Pseudonym) Evaluation Studies, FDA Phase I
English (Pseudonym) Human Microdosing Trial
English (Pseudonym) Phase 1 Clinical Trial
English (Pseudonym) Phase I Clinical Trial
English (Pseudonym) Phase I Clinical Trials
Slovak (Pseudonym) štúdie klinické, fáza I
Slovak (Pseudonym) štúdie klinické, fáza I, ako téma
Slovak (Pseudonym) pokusy klinické, prvá fáza, ako téma
Slovak (Pseudonym) testy klinické, prvá fáza, ako téma
Slovak (Pseudonym) štúdie vyhodnocovacie, FDA fáza I, ako téma
Slovak (Pseudonym) štúdie vyhodnocovacie, FDA fáza I
Slovak (Pseudonym) štúdie hodnotiace, FDA fáza 1, ako téma
Slovak (Pseudonym) hodnotenie liekov, FDA fáza I, ako téma
Slovak (Pseudonym) štúdia mikrodávková humánna
Slovak (Pseudonym) skúška klinická, fáza 1
See also (Skutočné meno) experimentovanie na ľuďoch, neterapeutické
(Later heading) experimentovanie na ľuďoch, neterapeutické
UDC E05.318.372.250.250.200N05.715.360.330.250.250.200N06.850.520.450.250.250.200 Note Works about studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries. 
subject heading
Number of the records: 1